Evidence map›Paper›PMID 42142268›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Unveiling silent CAD in an oncology patient: stress delayed defect filling of [¹⁸F]Flurpiridaz as a potential viability biomarker.

Yunfeng Wang, Zhixing Qin, Zhenyu Xiang, Yulong Dou, Kewei Zhou, Lili Wang, Yanjie Hou, Sijin Li, Ping Wu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yunfeng WangDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China.
Zhixing QinDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China.
Zhenyu XiangDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China.
Yulong DouDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China.
Kewei ZhouDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China.
Lili Wang³Department of Radiation Oncology, First Hospital of Shanxi Medical University, Taiyuan, China.
Yanjie Hou³Department of Radiation Oncology, First Hospital of Shanxi Medical University, Taiyuan, China.
Sijin LiDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China.
Ping WuDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan, China. wuping_0815@163.com.ORCID http://orcid.org/0000-0003-2397-2761

Funding

Fundamental Research Program of Shanxi Province 202503021211276National Natural Science Foundation of China U22A6008Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province 20230049
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42142268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.